Cns Pharmaceuticals Inc (CNSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 910 | 4,279 | 5,111 | 10,055 | 7,028 |
| TOTAL | $2,062 | $6,071 | $6,972 | $12,565 | $8,700 |
| Non-Current Assets | |||||
| PPE Net | 4 | 3 | 4 | 6 | 9 |
| Other Non-Current Assets | 263 | 377 | 438 | 483 | 929 |
| TOTAL | $266 | $381 | $443 | $489 | $938 |
| Total Assets | $2,328 | $6,452 | $7,415 | $13,053 | $9,638 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,027 | 3,571 | 2,781 | 4,510 | 1,005 |
| Accrued Expenses | N/A | 260 | 853 | N/A | 200 |
| TOTAL | $4,069 | $3,997 | $3,923 | $4,920 | $1,244 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $4,069 | $3,997 | $3,923 | $4,920 | $1,244 |
| Shareholders' Equity | |||||
| Common Shares | 4 | 4 | 2 | 2 | 40 |
| Retained earnings | -64,192 | -59,669 | -55,648 | -50,716 | -44,753 |
| TOTAL | $-1,741 | $2,454 | $3,492 | $8,133 | $8,394 |
| Total Liabilities And Equity | $2,328 | $6,452 | $7,415 | $13,053 | $9,638 |